Efficacy of SLITone in House Dust Mite Allergic Patients
Status:
Completed
Trial end date:
2009-02-01
Target enrollment:
Participant gender:
Summary
This trial has been designed to evaluate the efficacy of specific immunotherapy with SLITone
Dermatophagoides mix compared with placebo in subjects with house dust mite allergic asthma,
based on asthma medication use during a period of 2 months with a high environmental exposure
to mites (autumn 2008).